Amplia Therapeutics Limited (INNMF)
USD 0.04
(-12.5%)
USD 0.04
(-12.5%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 14.84 Million AUD | -20.55% |
| 2023 | 18.68 Million AUD | -23.69% |
| 2022 | 24.48 Million AUD | 125.05% |
| 2021 | 10.87 Million AUD | 19.34% |
| 2020 | 9.11 Million AUD | -0.82% |
| 2019 | 9.19 Million AUD | 247.67% |
| 2018 | 2.64 Million AUD | -64.92% |
| 2017 | 7.53 Million AUD | 49.7% |
| 2016 | 5.03 Million AUD | -5.35% |
| 2015 | 5.31 Million AUD | -47.73% |
| 2014 | 10.17 Million AUD | -10.94% |
| 2013 | 11.42 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 17.55 Million AUD | -6.02% |
| 2024 Q2 | 17.55 Million AUD | 0.0% |
| 2024 Q4 | 14.84 Million AUD | 0.0% |
| 2024 FY | 14.84 Million AUD | -20.55% |
| 2023 Q3 | 18.68 Million AUD | -14.44% |
| 2023 Q1 | 21.83 Million AUD | -10.81% |
| 2023 FY | 18.68 Million AUD | -23.69% |
| 2023 Q2 | 21.83 Million AUD | 0.0% |
| 2023 Q4 | 18.68 Million AUD | 0.0% |
| 2022 Q4 | 24.48 Million AUD | 0.0% |
| 2022 Q2 | 12.96 Million AUD | 0.0% |
| 2022 FY | 24.48 Million AUD | 125.05% |
| 2021 Q4 | 10.87 Million AUD | 0.0% |
| 2021 FY | 10.87 Million AUD | 19.34% |
| 2021 Q2 | 12.61 Million AUD | 0.0% |
| 2020 Q2 | 9.19 Million AUD | 0.0% |
| 2020 Q4 | 9.11 Million AUD | 0.0% |
| 2020 FY | 9.11 Million AUD | -0.82% |
| 2019 FY | 9.19 Million AUD | 247.67% |
| 2019 Q4 | 9.19 Million AUD | 0.0% |
| 2018 Q4 | 2.64 Million AUD | 0.0% |
| 2018 FY | 2.64 Million AUD | -64.92% |
| 2017 Q4 | 7.53 Million AUD | 0.0% |
| 2017 FY | 7.53 Million AUD | 49.7% |
| 2016 FY | 5.03 Million AUD | -5.35% |
| 2016 Q4 | 5.03 Million AUD | 0.0% |
| 2015 FY | 5.31 Million AUD | -47.73% |
| 2015 Q4 | 5.31 Million AUD | 0.0% |
| 2014 FY | 10.17 Million AUD | -10.94% |
| 2013 FY | 11.42 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 1.87 Million USD | -690.525% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -2874.739% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -5581.751% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -40.659% |
| GB Sciences, Inc. | 103.44 Thousand USD | -14251.142% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -65.883% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -82926.331% |
| Skye Bioscience, Inc. | 11.94 Million USD | -24.327% |
| Zenith Capital Corp. | 7410.00 USD | -200238.839% |
| Agentix Corp. | 261.39 Thousand USD | -5579.251% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -658.104% |
| Biomind Labs Inc. | 73.81 Thousand USD | -20010.145% |
| ContraFect Corporation | 20.67 Million USD | 28.212% |
| CSL Limited | 38.02 Billion USD | 99.961% |
| CytoDyn Inc. | 11.13 Million USD | -33.307% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1826.325% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 46.876% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -2989.146% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -20414.21% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4098.075% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 88.599% |
| SQZ Biotechnologies Company | 107.18 Million USD | 86.15% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -348.085% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 61.786% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -936.646% |
| Mesoblast Limited | 667.9 Million USD | 97.777% |
| Marizyme, Inc. | 22.01 Million USD | 32.568% |
| Genus plc | 1.02 Billion USD | 98.557% |
| Pharming Group N.V. | 462.85 Million USD | 96.793% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2267.641% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3784.354% |
| IMV Inc. | 31.33 Million USD | 52.623% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -258.057% |
| MultiCell Technologies, Inc. | 126.22 USD | -11761196.15% |
| ONE Bio Corp. | 70.08 Million USD | 78.819% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 88.448% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 57.801% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -924.618% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 50.541% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -440.543% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2059.332% |
| Alpha Cognition Inc. | 2.45 Million USD | -505.387% |
| Enzolytics Inc. | 361.7 Million USD | 95.896% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.673% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 68.879% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -2220.796% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.562% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -105.618% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -19342.476% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -4513.061% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -5579.86% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1499.756% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -992.876% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3702.869% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1479.789% |
| Helix BioMedix, Inc. | 3.02 Million USD | -390.733% |
| EV Biologics, Inc. | 431.71 Thousand USD | -3338.644% |
| Q BioMed Inc. | 3.51 Million USD | -322.274% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 71.831% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 96.674% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -1.956% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -470.265% |
| HST Global, Inc. | 1526.00 USD | -972711.796% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -642545.368% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1402.591% |
| Halberd Corporation | 10.13 Thousand USD | -146431.517% |
| Resverlogix Corp. | 8.11 Million USD | -82.934% |
| Cell Source, Inc. | 195.17 Thousand USD | -7506.206% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -65064.426% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.37 Million USD | -101.231% |
| Ember Therapeutics, Inc. | 184.00 USD | -8067893.478% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -23748.329% |
| Kadimastem Ltd | 2.3 Million USD | -544.297% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -15419.103% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -25901.17% |
| LadRx Corporation | 2.3 Million USD | -543.235% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4098.075% |
| Affymax, Inc. | 7.44 Million USD | -99.451% |
| Itoco Inc. | 1.4 Million USD | -960.31% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -13904.819% |
| Mobile Lads Corp. | 52.00 USD | -28548184.615% |
| International Stem Cell Corporation | 5.39 Million USD | -175.419% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 137.63 Thousand USD | -10685.617% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -10283.227% |
| Qrons Inc. | 420.00 USD | -3534449.524% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3751.161% |
| SYBLEU INC | 330.46 Thousand USD | -4392.147% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2588.747% |
| Rebus Holdings, Inc. | 5000.00 USD | -296802.16% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3525.87% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 1.045% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 10.458% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -18691.276% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1616.839% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -97.487% |
| Neutra Corp. | 2851.00 USD | -520598.281% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 54.19% |
| PureTech Health plc | 693.97 Million USD | 97.861% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -83.929% |
| IXICO plc | 15.84 Million USD | 6.304% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -79.245% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 85.632% |
| CSL Limited | 38.02 Billion USD | 99.961% |
| Cellectis S.A. | 333.99 Million USD | 95.555% |